The clinical relevance of these findings was further strengthened by the detection of characteristic elastase-cleaved EMILIN-1 fragments in human secondary lymphedema specimens [78], providing compelling evidence for neutrophil elastase inhibition as a viable treatment strategy. Here, EMILIN1 is linked to lymphedema.